Fig. 10From: Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinomaImmune and molecular characteristics of different risk score subgroups. A Immune cells between the high-risk score (Risk-H) and low-risk score (Risk-L) groups. B Gene sets enriched in the Risk-H group. C Gene sets enriched in the Risk-L group. ns, not significant, *, p < 0.05, **, p < 0.01, ***, p < 0.001, ****, p < 0.0001)Back to article page